Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on April 10, 2025
Congressman Honors Youth-Led Democratic Movement in Bangladesh and Meets with Activist Zahid F. Sarder Saddi to Discuss U.S. Support for Democratic Transition
GlobeNewswire
·
April 10, 2025
Washington, DC, April 10, 2025 (GLOBE NEWSWIRE) -- ❝ Congressman Honors Youth-Led Democratic Movement in Bangladesh and Meets with Zahid F. Sarder Saddi to Discuss U.S. Support for Democratic Transition❞ In a significant move recognizing the ongoing …
PCS Edventures! Announces 10 Million Share Repurchase Authorization
GlobeNewswire
·
April 10, 2025
BOISE, Idaho, April 10, 2025 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc. (“PCSV”), a leading provider of K-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced that its Board of Directors has authorized a share …
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center
GlobeNewswire
·
April 10, 2025
Empowering Young Entrepreneurs with AI in the Greater Bay Area of China CULVER CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- via IBN – Glidelogic Corp. (USOTC: GDLG) , "the Company"), a global leader in AI innovation, today announced a strategic …
Harvard Bioscience Announces CFO Transition
GlobeNewswire
·
April 10, 2025
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will be effective …
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
GlobeNewswire
·
April 10, 2025
BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event to foster conversations about new funding models and …
Arcutis Announces Chief Financial Officer Transition
GlobeNewswire
·
April 10, 2025
WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that David Topper, …
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
GlobeNewswire
·
April 10, 2025
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its …
SPS Commerce Announces Date of First Quarter 2025 Financial Results
GlobeNewswire
·
April 10, 2025
MINNEAPOLIS, April 10, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that it will issue its financial results for the first quarter ended March 31, 2025, after the market close …
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
GlobeNewswire
·
April 10, 2025
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
AvePoint to Announce First Quarter 2025 Financial Results on May 8
GlobeNewswire
·
April 10, 2025
JERSEY CITY, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- AvePoint (NASDAQ: AVPT), the global leader in data security, governance, and resilience, will report its first quarter 2025 financial results after the US financial markets close on Thursday, May 8, …
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …
Astera Labs Announces Conference Call to Review First Quarter 2025 Financial Results
GlobeNewswire
·
April 10, 2025
SANTA CLARA, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the …
Varonis Announces Date of First Quarter 2025 Financial Results
GlobeNewswire
·
April 10, 2025
MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced that it will report its first quarter 2025 financial results following the close of the U.S. financial markets Tuesday, May 6, 2025. In …
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
GlobeNewswire
·
April 10, 2025
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that two presentations and a panel …
Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact
GlobeNewswire
·
April 10, 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Folia Health launches enrollment for an innovative, at-home real-world evidence initiative for individuals with C3 glomerulopathy (C3G). Designed in partnership with C3G clinicians and patients, this study uses …
AppFolio, Inc. Announces Date of First Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
April 10, 2025
SANTA BARBARA, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its first quarter 2025 financial results after the close of the U.S. financial markets on Thursday, April 24, 2025. In conjunction …
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
GlobeNewswire
·
April 10, 2025
SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person investor …
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
GlobeNewswire
·
April 10, 2025
WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
GlobeNewswire
·
April 10, 2025
Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the …